Here's the Major Earnings Before the Open Tomorrow
Johnson & Johnson Snaps Six Straight Days of Gains
Lilly Sues Companies Selling Compounded Zepbound, Mounjaro
What's Going On With Kenvue Stock Monday?
Goldman's High Growth Investment Ratio Stocks: EA, AMZN, FANG, Etc
Goldman Sachs, Morgan Stanley Bullish on BioAge, Cite Lilly Relationship
Earnings Preview: Danaher
Novo Nordisk Semaglutide Cut Cardio Risks by 14% in Diabetics: Study
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
AbbVie Announces That 9 Canadian Provinces Have Provided Accelerated Public Coverage Of EPKINLY, A Treatment For Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
Buy ahead of time in 2016? Benefiting from the 'Trump trade,' assets are outpacing the market, but this time 'it's somewhat different.'
Republican presidential candidate Trump's polls are reversing, and the 'winning odds' are gradually increasing. A Merrill Lynch strategist pointed out that investors seem to be rushing to allocate to symbols that performed well after Trump's victory in 2016. What inspiration does this have for investment?
Earnings Week Ahead: TSLA, GE, GM, KO, PM, LUV, AAL, VZ, T and More
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
Activist Investor Starboard Takes Stake in Kenvue - WSJ
Three Events That Shook Health Insurers This Week
Over 60% of Companies That Reported Earnings This Week Beat EPS and Revenue Estimates - Earnings Scorecard
AbbVie Says Latest FDA Approval Expands Botox Use Beyond Face
Shares of Surgical Tool and Medical Instrument Stocks Are Trading Higher in Sympathy With Intuitive Surgical, Which Gained on Strong Q3 Earnings.
Tyra Raised to Buy by BofA Ahead of TYRA-300 Data Readout
'FDA Won't Take Action Against GLP-1 Compounders As It Rethinks Tirzepatide Shortage' - Endpoints News